The U.S government’s first look at the real-world use of COVID-19 vaccines found their effectiveness was nearly as robust as
A rare, rogue immune response is the main suspect as authorities investigate highly unusual blood clots following use of two similar COVID-19 vaccines from Johnson & Johnson and AstraZeneca. The